MLTX Competitors & Alternatives
Compare MoonLake Immunotherapeutics with similar stocks in the same industry
Biotechnology
MLTX
Main Stock$11.85
-5.20%
Tradestie Score
33
Market Cap
$448.32M
Analyst Upside
+155.6%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$47.74
-2.18%
|
$1.17B | - | 34 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$18.59
-2.34%
|
$1.15B | 8.1 | 54 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$13.30
-2.56%
|
$1.14B | - | 42 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$7.69
-2.23%
|
$1.14B | - | 45 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$34.16
-0.50%
|
$1.13B | - | 32 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$2.89
-7.82%
|
$1.12B | - | 32 | Compare |
|
NKTR
Nektar Therapeutics
|
$36.57
-1.88%
|
$1.12B | - | 59 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$309.08
-5.81%
|
$1.12B | - | 30 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$6.22
-2.74%
|
$1.09B | - | 38 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$12.58
-0.16%
|
$1.05B | 39.4 | 35 | Compare |
More MLTX Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry